S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
NASDAQ:GRPH

Graphite Bio News Headlines

$8.41
-0.61 (-6.76%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.35
$9.33
50-Day Range
$8.41
$20.15
52-Week Range
$8.11
$34.00
Volume
169,637 shs
Average Volume
331,424 shs
Market Capitalization
$488.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Media Mentions By Week



Graphite Bio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GRPH
News Sentiment

0.67

0.29

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GRPH Articles
This Week

1

1

GRPH Articles
Average Week

Get Graphite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRPH and its competitors with MarketBeat's FREE daily newsletter.

Graphite Bio (NASDAQ:GRPH) News Headlines Today

SourceHeadline
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Stock Price Down 7.1%
americanbankingnews.com - November 29 at 4:08 PM
MarketBeat logoGraphite Bio, Inc. (NASDAQ:GRPH) Major Shareholder Biocapital L.P. Samsara Purchases 201,685 Shares
americanbankingnews.com - November 24 at 2:10 PM
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Shares Up 6.9%
americanbankingnews.com - November 24 at 1:38 PM
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Hits New 52-Week Low at $10.48
americanbankingnews.com - November 22 at 11:00 AM
finance.yahoo.com logoGraphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease
finance.yahoo.com - November 17 at 10:05 AM
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Sets New 12-Month Low at $11.61
americanbankingnews.com - November 15 at 12:43 PM
MarketBeat logoGraphite Bio, Inc. Expected to Earn FY2021 Earnings of ($2.34) Per Share (NASDAQ:GRPH)
americanbankingnews.com - November 15 at 1:58 AM
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Rating Reiterated by SVB Leerink
americanbankingnews.com - November 14 at 11:50 AM
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Posts Earnings Results, Hits Expectations
americanbankingnews.com - November 11 at 5:05 PM
finance.yahoo.com logoGraphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results
finance.yahoo.com - November 10 at 7:51 PM
MarketBeat logoGraphite Bio (NASDAQ:GRPH) Stock Price Up 10.1%
americanbankingnews.com - November 8 at 2:48 PM
finance.yahoo.com logoGraphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit
finance.yahoo.com - October 21 at 10:44 AM
finance.yahoo.com logo10% Owner Of Graphite Bio Makes $670K Buy
finance.yahoo.com - October 18 at 5:26 PM
finance.yahoo.com logoGraphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention
finance.yahoo.com - October 12 at 2:08 PM
finance.yahoo.com logoGraphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National Convention
finance.yahoo.com - October 5 at 8:33 AM
nasdaq.com logoGraphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans
nasdaq.com - September 25 at 7:25 PM
finance.yahoo.com logoWe Think Graphite Bio (NASDAQ:GRPH) Can Afford To Drive Business Growth
finance.yahoo.com - September 25 at 2:24 PM
finance.yahoo.com logoGraphite Bio Announces Participation in Upcoming September Investor Conferences
finance.yahoo.com - August 30 at 8:21 AM
nasdaq.com logoNew 52-Week Low Could Prompt More Insider Buying At GRPH
nasdaq.com - August 20 at 4:06 PM
finance.yahoo.com logoGraphite Bio Reports Recent Business Progress and Second Quarter 2021 Financial Results
finance.yahoo.com - August 12 at 4:29 PM
ca.finance.yahoo.com logoGraphite Bio, Inc. (GRPH)
ca.finance.yahoo.com - July 21 at 7:41 PM
markets.businessinsider.com logoGraphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
markets.businessinsider.com - July 20 at 6:37 PM
nasdaq.com logoGraphite Bio, Inc. Common Stock (GRPH)
nasdaq.com - July 16 at 11:43 PM
finance.yahoo.com logoGraphite Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 30 at 8:46 PM
finance.yahoo.com logoGraphite Bio Announces Pricing of Upsized Initial Public Offering
finance.yahoo.com - June 28 at 8:28 AM
Get Graphite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRPH and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.